Literature DB >> 35668706

HIV-Associated Alterations of the Biophysical Features of Maternal Antibodies Correlate With Their Reduced Transfer Across the Placenta.

Sean A Taylor1, Shilpee Sharma2, Christopher A L Remmel1, Beth Holder3, Christine E Jones4,5,6, Arnaud Marchant2, Margaret E Ackerman1.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) infection during pregnancy is associated with reduced transplacental transfer of maternal antibodies and increased risk of severe infections in children who are exposed and uninfected with HIV. The basis of this reduced transfer of maternal immunity has not yet been defined but could involve modifications in the biophysical features of antibodies. The objective of this study was to assess the impact of maternal HIV infection on the biophysical features of serum IgG and transplacental antibody transfer.
METHODS: Maternal serum IgG subclass levels, Fc glycosylation, Fc receptor (FcR) binding, and transplacental transfer of pathogen-specific maternal IgG were measured in pregnant women with HIV (WWH) and pregnant women testing negative for HIV (WNH) in Cape Town, South Africa.
RESULTS: Maternal antibody profiles were strikingly different between pregnant WWH and WNH. Antibody binding to FcγR2a and FcγR2b, IgG1 and IgG3 antibodies, and agalactosylated antibodies were all elevated in WWH, whereas digalactosylated and sialylated antibodies were reduced compared to pregnant WNH. Antibody features that were elevated in WWH were also correlated with reduced transplacental transfer of vaccine antigen-specific antibodies.
CONCLUSIONS: HIV infection is associated with marked alterations of biophysical features of maternal IgG and reduced placental transfer, potentially impairing antimicrobial immunity.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Fc receptors; HIV infection; IgG; pregnancy; transplacental transfer

Mesh:

Substances:

Year:  2022        PMID: 35668706      PMCID: PMC9574667          DOI: 10.1093/infdis/jiac222

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  47 in total

1.  The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  MAbs       Date:  2016-08-05       Impact factor: 5.857

2.  Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection.

Authors:  M I de Moraes-Pinto; A C Almeida; G Kenj; T E Filgueiras; W Tobias; A M Santos; M M Carneiro-Sampaio; C K Farhat; P J Milligan; P M Johnson; C A Hart
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

3.  Expression of the neonatal Fc-receptor in placental-fetal endothelium and in cells of the placental immune system.

Authors:  Terezia Kiskova; Yuliya Mytsko; Martin Schepelmann; Hanns Helmer; Renate Fuchs; Heidi Miedl; Christian Wadsack; Isabella Ellinger
Journal:  Placenta       Date:  2019-02-28       Impact factor: 3.481

4.  A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children.

Authors:  Alana T Brennan; Rachael Bonawitz; Christopher J Gill; Donald M Thea; Mary Kleinman; Johanna Useem; Lindsey Garrison; Rachel Ceccarelli; Chinenye Udokwu; Lawrence Long; Matthew P Fox
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

5.  Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.

Authors:  Stephen J Kerr; Thanyawee Puthanakit; Ung Vibol; Linda Aurpibul; Sophan Vonthanak; Pope Kosalaraksa; Suparat Kanjanavanit; Rawiwan Hansudewechakul; Jurai Wongsawat; Wicharn Luesomboon; Kattiya Ratanadilok; Wasana Prasitsuebsai; Kanchana Pruksakaew; Jasper van der Lugt; Robert Paul; Jintanat Ananworanich; Victor Valcour
Journal:  AIDS Care       Date:  2014-05-30

Review 6.  Transfer of maternal immunity and programming of the newborn immune system.

Authors:  Madeleine F Jennewein; Bahaa Abu-Raya; Yiwei Jiang; Galit Alter; Arnaud Marchant
Journal:  Semin Immunopathol       Date:  2017-10-02       Impact factor: 9.623

Review 7.  HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination.

Authors:  Ceri Evans; Christine E Jones; Andrew J Prendergast
Journal:  Lancet Infect Dis       Date:  2016-03-31       Impact factor: 25.071

8.  Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G.

Authors:  Helga K Einarsdottir; Maurice H J Selman; Rick Kapur; Sicco Scherjon; Carolien A M Koeleman; André M Deelder; C Ellen van der Schoot; Gestur Vidarsson; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2012-05-10       Impact factor: 2.916

9.  Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.

Authors:  Albert Bondt; Yoann Rombouts; Maurice H J Selman; Paul J Hensbergen; Karli R Reiding; Johanna M W Hazes; Radboud J E M Dolhain; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2014-07-08       Impact factor: 5.911

Review 10.  Mortality risk and associated factors in HIV-exposed, uninfected children.

Authors:  Shino Arikawa; Nigel Rollins; Marie-Louise Newell; Renaud Becquet
Journal:  Trop Med Int Health       Date:  2016-04-19       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.